Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine
Your brain on drugs: Psychedelic therapeutic Cybin and neuroimaging technology startup Kernel will examine patients' brains while they are taking ketamine. getty The U.S. Food and Drug Administration has approved a clinical trial using a Los Angeles-based Kernel neuroimaging helmet to track what happens in the brain when a person takes a psychedelic dose of ketamine. Cybin, a Toronto-based psychedelic therapeutic startup, is sponsoring the study. The study will begin before the end of the year in 15 patients at a ketamine-assisted therapy clinic in Marina Del Rey, California. All patients go through two rounds of the study. The first will be a placebo session of saline so that the Kernel Flow brain imaging device can get a baseline of the patient's neurological activity, and the second session will give patients an intramuscular injection of a psychedelic dose of ketamine while doing the Kernel Flow. Wear a headset. Alex Belser, Cybin's Chief Clinical Office...